FIELD: biotechnology.
SUBSTANCE: method for vaccine production involves virus antigen cultivation in BHK-21 suspension cell culture at a temperature of 36-37°C, virus suspension purification from ballast admixtures, inactivation, concentration of foot-and-mouth disease virus antigen obtained and antigen concentrate combination with an adjuvant. After 6-8 hours of virus antigen cultivation, percentage of dead cells is registered every 2 hours. When the level of dead cells reaches 95% or more, further cultivation is performed for 2-8 hours depending on the virus type. Foot-and-mouth disease vaccine obtained by this method contains antigen material of A-type and/or O-type and/or Asia-1 type foot-and-mouth disease viruses in an effective quantity of 146S-component, aluminium hydroxide gel, saponin and maintenance medium.
EFFECT: method allows to increase the amount of antigenic material in terms of 146S-component during foot-and-mouth disease virus cultivation, and the vaccine obtained by this method is harmless, avirulent and immunogenic.
13 cl, 1 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OBTAINING FOOT-AND-MOUTH DISEASE VACCINE AND FOOT-AND-MOUTH DISEASE VACCINE | 2007 |
|
RU2332233C1 |
VACCINATION AGAINST FOOT AND MOUTH DISEASE AND METHOD FOR ITS PRODUCTION AND USE | 2016 |
|
RU2617043C1 |
METHOD OF PRODUCTION OF VACCINE AGAINST FOOT-AND-MOUTH DISEASE | 2013 |
|
RU2522868C1 |
VACCINE AGAINST O-TYPE FOOT-AND-MOUTH DISEASE AND METHOD FOR ITS PREPARING | 2001 |
|
RU2212895C2 |
VACCINE AGAINST FOOT-AND-MOUTH ASIA-1 TYPE AND METHOD FOR IT PREPARING | 2002 |
|
RU2220744C1 |
VACCINE AGAINST FOOT AND MOUTH OF TYPE A AND METHOD OF ITS PREPARING | 1999 |
|
RU2143921C1 |
SORBED INACTIVATED VACCINE AGAINST FOOT-AND-MOUTH DISEASE OF TYPE A | 2004 |
|
RU2294760C2 |
INACTIVATED SORPTIVE FOOT-AND-MOUTH DISEASE TYPE A VACCINE | 2014 |
|
RU2562547C1 |
INACTIVATED SORBENT TYPE A FOOT-AND-MOUTH DISEASE VACCINE | 2012 |
|
RU2526570C2 |
METHOD OF MANUFACTURING THE VACCINE INACTIVATED EMULSION AGAINST MURRAIN AND EMULSION INACTIVATED VACCINE AGAINST MURRAIN | 2017 |
|
RU2652889C1 |
Authors
Dates
2017-09-19—Published
2007-05-21—Filed